Figure 4
From: Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer
Study design. The cohort of Step1 was targeting the patients evident the results of CD-DST. The cohort of Step2 is targeting the PDAC patients with S-1 adjuvant chemotherapy. We set no adjuvant patients group as control cohort of this study. CD-DST collagen gel droplet embedded drug sensitivity test, PDAC pancreatic ductal adenocarcinoma.
